Page last updated: 2024-10-21

1-(3-chlorophenyl)piperazine and Chronic Illness

1-(3-chlorophenyl)piperazine has been researched along with Chronic Illness in 2 studies

1-(3-chlorophenyl)piperazine: supposed metabolite of TRAZODONE; RN given refers to parent cpd; structure
1-(3-chlorophenyl)piperazine : A N-arylpiperazine that is piperazine carrying a 3-chlorophenyl substituent at position 1. It is a metabolite of the antidepressant drug trazodone.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lindenmayer, JP1
Vital-Herne, M1
Bark, N1
Grochowski, S1
Moynihan, N1
Iqbal, N1
Asnis, GM1
Wetzler, S1
Kahn, RS1
Kay, SR1
van Praag, HM1

Trials

2 trials available for 1-(3-chlorophenyl)piperazine and Chronic Illness

ArticleYear
Heterogeneity of serotonergic response in treatment-refractory schizophrenia patients.
    Biological psychiatry, 1997, Jul-01, Volume: 42, Issue:1

    Topics: Adult; Antipsychotic Agents; Chronic Disease; Double-Blind Method; Female; Humans; Hydrocortisone; M

1997
The MCPP challenge test in schizophrenia: hormonal and behavioral responses.
    Biological psychiatry, 1991, Oct-15, Volume: 30, Issue:8

    Topics: Adult; Chronic Disease; Double-Blind Method; Humans; Hydrocortisone; Male; Piperazines; Prolactin; P

1991